gdc
Submit Your Story Submit Your Art
Subscribe

Urothelial Cancer

Jelmyto First FDA-Approved Therapy for Low-Grade Upper-Tract Urothelial Cancer
Bladder CancerFDA Approvals, News & UpdatesUrothelial Cancer
Jelmyto First FDA-Approved Therapy for Low-Grade Upper-Tract Urothelial Cancer
Web Exclusives
In April 2020, the FDA approved Jelmyto as the first treatment for low-grade upper-tract urothelial cancer, a rare cancer that affects the urinary system.

Results 1 - 1 of 1

Subscribe to CONQUER™: the patient voice™ magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest